Cytoskeletal involvement in the regulation of aqueous humor outflow.
Cytoskeletal involvement in the regulation of aqueous humor outflow.
复制标题
DOI:
--
复制
发表时间:
2000-03
影响因子:
4.4
通讯作者:
B. Tian;Benjamin Geiger;David L. Epstein;Paul L. Kaufman
中科院分区:
文献类型:
--
作者:
B. Tian;Benjamin Geiger;David L. Epstein;Paul L. Kaufman
Fluid flow in the anterior chamber maintains intraocular pressure (IOP) and globe shape and supplies oxygen and nutrients to the nonvascularized cornea, lens, and trabecular meshwork (TM). Glaucoma is a progressive optic neuropathy often caused by elevated IOP consequent to abnormally high resistance to aqueous humor drainage via the TM and Schlemm’s canal. Compounds with cytoskeletal effects offer therapeutic possibilities for substantial long-term IOP reduction. Most current IOP-reducing agents either suppress aqueous humor production or increase outflow through the ciliary muscle, thus reducing aqueous humor flow through the TM, perhaps compromising an already compromised tissue and potentially stressing the cornea and lens. Glaucoma patients usually receive several of these agents concurrently. Recent studies indicate that the TM cytoskeleton may be involved in the regulation of aqueous humor outflow. A cytoskeletal agent acting directly on the TM/Schlemm’s canal to reduce outflow resistance would be more consistent with normal physiological function, and recent developments indicate that this approach is moving toward fruition. FUNCTIONAL ORGANIZATION OF THE TM The TM consists of arrays of collagen beams covered by endothelium-like cells, with extracellular material/matrix (ECM) occupying the spaces between the beams. The outermost juxtacanalicular or cribriform region has no collagenous beams but rather several cell layers immersed in loose ECM. The adjacent Schlemm’s canal is a continuous endothelium-lined channel that drains aqueous humor to the general venous circulation. Trabecular meshwork structure and experimental flow studies suggest that flow resistance is maximal in the outermost region, but the exact location and nature of the major resistance barrier, and the exact flow pathways through the TM and the inner wall of Schlemm’s canal, are not clear either in the normal or the glaucomatous eye. With age, resistance increases, TM cells decrease, and alterations of the ECM in the juxtacanalicular region occur. Glaucomatous eyes exhibit fewer TM cells and abnormal-appearing juxtacanalicular ECM compared with age-matched normals, all suggesting that cells and ECM in the juxtacanalicular region may be critical in resistance regulation. Cell shape, volume, contractility, and adhesion to neighboring cells and to the ECM, and amount and composition of the ECM, could affect resistance by altering the dimensions or direction of flow pathways and could be therapeutic targets to reduce flow resistance.